LLY
股票Eli Lilly and Co
- 总部
- US
- 行业
- 制药
- 发行时间
- 1985-01-13
- 流通股
- 942M
区间表现
2 小时前关键指标
2 小时前- 市值
- $1.02T
- 企业价值
- $1.05T
- 市盈率 (TTM)
- 40.16
- 预期市盈率
- 27.51
- 市盈率 (年)
- 49.19
- PEG
- 1.37
- 市净率
- 38.29
- 市销率 (TTM)
- 14.05
- 市销率 (年)
- 15.58
- EV / EBITDA
- 31.38×
- EV / 营收
- 14.58×
- 每股收益 (TTM)
- $28.15
- 每股收益 (年)
- $22.95
- 基本每股收益 (TTM)
- $28.15
- 每股净资产
- $28.09
- 毛利率
- 82.83%
- 营业利润率
- 43.63%
- 净利率
- 34.99%
- 净资产收益率 (ROE)
- 101.31%
- 总资产收益率 (ROA)
- 22.73%
- 投资回报率 (ROI)
- 37.71%
- 每股 EBITDA
- $37.37
- 每股营收 (TTM)
- $80.64
- 营收增长 (TTM YoY)
- +47.44%
- 营收增长 (季 YoY)
- +55.55%
- EPS 增长 (TTM YoY)
- +128.83%
- 股息率 (预期)
- 0.64%
- 股息率 (TTM)
- 0.55%
- 每股股息 (TTM)
- $5.91
- 派息率
- 22.10%
- 流动比率
- 1.58
- 速动比率
- 0.78
- 负债权益比
- 1.60
- 长期负债权益比
- 1.54
- Beta
- 0.52
- 波动率 (3M)
- 37.57%
分析师评级
2 小时前财报
2 小时前相关新闻
2 小时前- Yahoo·7 天前companyTop Midday Stories: Micron's Market Cap Briefly Hits $1 Trillion; Qualcomm Reportedly Strikes AI Chip Deal With ByteDance
The Nasdaq Composite and S&P 500 were up, while the Dow Jones Industrial Average was down slightly t
- Yahoo·7 天前companyNational Advertising Division Recommends Noom Modify or Discontinue “A Smaller Dose. A Smarter Start” Claim for Microdose GLP-1 Program
In a challenge brought by Eli Lilly and Company, BBB National Programs’ National Advertising Division recommended that Noom, Inc. modify or discontinue its Microdose GLP-1RX Program “A Smaller Dose. A SmarterStart” claim.New York, NY, May 26, 2026 (GLOBE NEWSWIRE) -- In a challenge brought by Eli Lilly and Company, BBB National Programs’ National Advertising Division recommended that Noom, Inc. modify or discontinue its Microdose GLP-1RX Program “A Smaller Dose. A SmarterStart” claim. Lilly and
- Yahoo·7 天前companyCan EU Label Expansions of NVO's GLP-1 Drugs Spur Sales Growth?
Novo Nordisk's EU label expansions may widen semaglutide use and boost volumes, but pricing pressure and Lilly rivalry can limit recovery.
- Yahoo·7 天前companyMicron tops $1 trillion in market cap as UBS sees company becoming an AI giant
Micron stock rose after UBS said the AI boom has changed the memory chip market — and tripled its price target to a Street high.
- Yahoo·7 天前companyMicron briefly tops $1 trillion in market cap as UBS sees company becoming an AI giant
Micron stock rose after UBS said the AI boom has changed the memory chip market — and tripled its price target to a Street high.
- Benzinga·7 天前companyFrom Shingles To Superbugs: Eli Lilly Expands Infectious Disease Push In Billion-Dollar Buying Wave
Eli Lilly acquires Curevo, LimmaTech, and Vaccine Co. to expand its infectious disease portfolio and advance long-term disease prevention.
- Benzinga·7 天前companyB of A Securities Maintains Buy on Eli Lilly, Raises Price Target to $1251
B of A Securities analyst Jason Gerberry maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1133 to $1251.
- Yahoo·7 天前companyEli Lilly to buy trio of vaccine developers in $3.8bn outlay
Via the deals, Lilly is buying biotechs with lead programmes in preventing shingles, bacteria, and Epstein-Barr Virus.
